Several national pharmacy associations are asking the FDA to offer a blanket exemption, waiver or exception from the Drug Supply Chain Security Act. 

Swiss pharmaceutical company Sandoz is launching a generic semaglutide, the main ingredient of Ozempic, in the U.S. when the market opens in 2030, Bloomberg reported Sept. 3.

The sole suppliers for a few medications, including a Parkinson's disease therapy, are reporting new drug shortages. 

Emergent BioSolutions' smallpox vaccine is now FDA-approved for the prevention of mpox, the drugmaker said Aug. 29. 

Meijer, a grocery store chain with more than 500 locations, has opened its second retail pharmacy inside a Corewell Health hospital. 

A federal lawmaker investigating pharmacy benefit managers is accusing top executives from CVS Health, Cigna Group and UnitedHealth Group of making false statements during a committee hearing in July.

Physicians are increasingly comfortable prescribing weight loss drugs such as Wegovy and Zepbound as new potential uses emerge, but cost and access challenges remain persistent hurdles.

The American Society of Health-System Pharmacies is speaking out against Johnson & Johnson's plan to drop upfront discounts for some 340B drugs.

Following a similar move from Eli Lilly, Pfizer launched a platform Aug. 27 to sell migraine, COVID-19 and flu products directly to consumers.

Eli Lilly has started selling single-dose vials of its blockbuster weight loss drug Zepbound for roughly half of its usual monthly list price.